Immunodominance of poxviral-specific CTL in a human trial of recombinant-modified vaccinia Ankara.

Immunodominance of poxviral-specific CTL in a human trial of recombinant-modified vaccinia Ankara.

Many recombinant poxviral vaccines are currently in clinical trials for cancer and infectious diseases. However, these agents have failed to generate T cell responses specific for recombinant gene products at levels comparable with T cell responses associated with natural viral infections. The recen...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Smith, C, Mirza, F, Pasquetto, V, Tscharke, D, Palmowski, M, Dunbar, P, Sette, A, Harris, A, Cerundolo, V
Формат:	Journal article
Хэл сонгох:	English
Хэвлэсэн:	2005

Ижил төстэй зүйлс

Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrence.
-н: Smith, C, зэрэг
Хэвлэсэн: (2005)

Immunodomination during peripheral vaccinia virus infection.
-н: Leon C W Lin, зэрэг
Хэвлэсэн: (2013-01-01)

Mucosal immunization with PLGA-microencapsulated DNA primes a SIV-specific CTL response revealed by boosting with cognate recombinant modified vaccinia virus Ankara.
-н: Sharpe, S, зэрэг
Хэвлэсэн: (2003)

Generation of an immunodominant CTL epitope is affected by proteasome subunit composition and stability of the antigenic protein.
-н: Gileadi, U, зэрэг
Хэвлэсэн: (1999)

Improved Host Range Selection for Recombinant Modified Vaccinia Virus Ankara
-н: Caroline Staib, зэрэг
Хэвлэсэн: (2003-04-01)

Recombinant modified vaccinia virus Ankara efficiently restimulates human cytotoxic T lymphocytes in vitro.
-н: Dorrell, L, зэрэг
Хэвлэсэн: (2000)

Induction of potent antitumor CTL responses by recombinant vaccinia encoding a melan-A peptide analogue.
-н: Valmori, D, зэрэг
Хэвлэсэн: (2000)

New approaches for improving the immunogenicity of modified vaccinia virus Ankara as a recombinant vaccine vector
-н: Alharbi, N
Хэвлэсэн: (2014)

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans.
-н: McConkey, S, зэрэг
Хэвлэсэн: (2003)

Clinical development of Modified Vaccinia virus Ankara vaccines.
-н: Gilbert, S
Хэвлэсэн: (2013)

Clinical development of Modified Vaccinia virus Ankara vaccines
-н: Gilbert, S
Хэвлэсэн: (2013)

Safety and immunogenicity of novel recombinant BCG and modified vaccinia virus Ankara vaccines in neonate rhesus macaques.
-н: Rosario, M, зэрэг
Хэвлэсэн: (2010)

Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice.
-н: Hanke, T, зэрэг
Хэвлэсэн: (1998)

Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen.
-н: Allen, T, зэрэг
Хэвлэсэн: (2000)

Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA).
-н: Matthew G Cottingham, зэрэг
Хэвлэсэн: (2008-02-01)

Dendritic cells infected by recombinant modified vaccinia virus Ankara retain immunogenicity in vivo despite in vitro dysfunction.
-н: Behboudi, S, зэрэг
Хэвлэсэн: (2004)

Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA).
-н: Cottingham, M, зэрэг
Хэвлэсэн: (2008)

Selection of Vaccinia Virus Recombinants Using CRISPR/Cas9
-н: Anjali Gowripalan, зэрэг
Хэвлэсэн: (2021-12-01)

Poxviral Ankyrin Proteins
-н: Michael H. Herbert, зэрэг
Хэвлэсэн: (2015-02-01)

Correction: Recombination-Mediated Genetic Engineering of a Bacterial Artificial Chromosome Clone of Modified Vaccinia virus Ankara (MVA).
-н: Matthew G. Cottingham, зэрэг
Хэвлэсэн: (2011-01-01)

Boosting BCG with recombinant modified vaccinia ankara expressing antigen 85A: different boosting intervals and implications for efficacy trials.
-н: Ansar A Pathan, зэрэг
Хэвлэсэн: (2007-10-01)

Transient Host Range Selection for Genetic Engineering of Modified Vaccinia Virus Ankara
-н: C. Staib, зэрэг
Хэвлэсэн: (2000-06-01)

Induction of simian immunodeficiency virus (SIV)-specific CTL in rhesus macaques by vaccination with modified vaccinia virus Ankara expressing SIV transgenes: influence of pre-existing anti-vector immunity.
-н: Sharpe, S, зэрэг
Хэвлэсэн: (2001)

Development of Modified Vaccinia Virus Ankara-Based Vaccines: Advantages and Applications
-н: Olga Vladimirovna Orlova, зэрэг
Хэвлэсэн: (2022-09-01)

Elements in the Development of a Production Process for Modified Vaccinia Virus Ankara
-н: Volker Sandig, зэрэг
Хэвлэсэн: (2013-11-01)

Correction: Recombination-Mediated Genetic Engineering of a Bacterial Artificial Chromosome Clone of Modified Vaccinia virus Ankara (MVA)
Хэвлэсэн: (2011-01-01)

Boosting BCG with Recombinant Modified Vaccinia Ankara Expressing Antigen 85A: Different Boosting Intervals and Implications for Efficacy Trials
-н: Pathan, A, зэрэг
Хэвлэсэн: (2007)

Correction: Boosting BCG with Recombinant Modified Vaccinia Ankara Expressing Antigen 85A: Different Boosting Intervals and Implications for Efficacy Trials.
-н: Ansar A. Pathan, зэрэг
Хэвлэсэн: (2011-01-01)

Boosting BCG with recombinant modified vaccinia ankara expressing antigen 85A: different boosting intervals and implications for efficacy trials.
-н: Pathan, A, зэрэг
Хэвлэсэн: (2007)

Diseño y construcción de vectores de transferencia para la obtención de virus vaccinia Ankara modificado (MVA) recombinantes Design and construction of transfer vectors in order to obtain recombinant modified vaccinia virus Ankara (MVA)
-н: M. F. Ferrer, зэрэг
Хэвлэсэн: (2007-09-01)

Safety and immunogenicity of DNA/modified vaccinia virus ankara malaria vaccination in African adults.
-н: Moorthy, V, зэрэг
Хэвлэсэн: (2003)

Synthetic modified vaccinia Ankara vaccines confer cross-reactive and protective immunity against mpox virus
-н: Flavia Chiuppesi, зэрэг
Хэвлэсэн: (2024-02-01)

Methods of treating Poxviral Infections
-н: Ramstedt, U, зэрэг
Хэвлэсэн: (2011)

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans.
-н: McShane, H, зэрэг
Хэвлэсэн: (2004)

Induction of antibody responses to African horse sickness virus (AHSV) in ponies after vaccination with recombinant modified vaccinia Ankara (MVA).
-н: Rachael Chiam, зэрэг
Хэвлэсэн: (2009-06-01)

The third generation modified vaccinia Ankara vaccine is effective in preventing the transmission of mpox
-н: Mingwang Shen, зэрэг
Хэвлэсэн: (2024-10-01)

Modified Vaccinia virus Ankara-based vaccines in the era of personalized immunotherapy of cancer
-н: Kaïdre Bendjama, зэрэг
Хэвлэсэн: (2017-09-01)

Hazard Characterization of Modified Vaccinia Virus Ankara Vector: What Are the Knowledge Gaps?
-н: Malachy I. Okeke, зэрэг
Хэвлэсэн: (2017-10-01)

Nodular Dermatitis: Emergence of Novel Poxviral Infection in Russia
-н: S. V. Borisevich, зэрэг
Хэвлэсэн: (2018-04-01)

Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara.
-н: Webster, D, зэрэг
Хэвлэсэн: (2005)